Abstract:Background The first community transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC) in Guangzhou, China occurred between May and June 2021. Herein, we describe the epidemiological characteristics of this outbreak and evaluate the implemented containment measures against this outbreak. Methodology/Principal findings Guangzhou Center for Disease Control and Prevention provided the data on SARS-CoV-2 infections reported between 21 May and 24 June 2021. We estimated the incubation period distribution by fitting a gamma distribution to the data, while the serial interval distribution was estimated by fitting a normal distribution. The instantaneous effective reproductive number (R-t) was estimated to reflect the transmissibility of SARS-CoV-2. Clinical severity was compared for cases with different vaccination statuses using an ordinal regression model after controlling for age. Of the reported local cases, 7/153 (4.6%) were asymptomatic. The median incubation period was 6.02 (95% confidence interval [CI]: 5.42-6.71) days and the means of serial intervals decreased from 5.19 (95% CI: 4.29-6.11) to 3.78 (95% CI: 2.74-4.81) days. The incubation period increased with age (P< 0.001). A hierarchical prevention and control strategy against COVID-19 was implemented in Guangzhou, with Rt decreasing from 6.83 (95% credible interval [CrI]: 3.98-10.44) for the 7-day time window ending on 27 May 2021 to below 1 for the time window ending on 8 June and thereafter. Individuals with partial or full vaccination schedules with BBIBP-CorV or CoronaVac accounted for 15.3% of the COVID-19 cases. Clinical symptoms were milder in partially or fully vaccinated cases than in unvaccinated cases (odds ratio [OR] = 0.26 [95% CI: 0.07-0.94]). Conclusions/Significance The hierarchical prevention and control strategy against COVID-19 in Guangzhou was timely and effective. Authorised inactivated vaccines are likely to contribute to reducing the probability of developing severe disease. Our findings have important implications for the containment of COVID-19. Author summary On 11 May 2021, the WHO reclassified the B.1.617.2 variant as a "variant of concern" (VOC) from being a "variant of interest", considering its global public health significance. On 21 May 2021, the first local case infected with the Delta variant (i.e. lineage B.1.617.2) in Guangzhou, China, was reported. In response to the resurgence of COVID-19, the local government implemented a series of containment measures. This provides a valuable opportunity to understand the characteristics of the Delta variant and to evaluate the performance of inactivated COVID-19 vaccines (BBIBP-CorV and CoronaVac) and other interventions. We estimated that the median incubation period was 6.02 days and the means of serial intervals decreased from 5.19 to 3.78 days. The incubation period increased with age. The vaccination coverage in the COVID-19 cases was 15.3%. Clinical symptoms were milder in cases with partial or full vaccination than in those who were unvaccinated (odds ratio [OR] = 0.26). We found that the effective reproductive number decreased from 6.83 for the 7-day time window ending on 27 May 2021 to below 1 for the time window ending on 8 June and thereafter. Our findings have important implications for the containment of COVID-19.

Genomic surveillance of a resurgence of COVID-19 in Guangzhou, China

Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.

Genomic Epidemiology of Imported Cases of COVID-19 in Guangdong Province,China,October 2020–May 2021

Genomic Surveillance of COVID-19 Cases in Beijing.

Genomic epidemiology reveals early transmission of SARS-CoV-2 and mutational dynamics in Nanning, China

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Genomic Surveillance of Emerging SARS-CoV-2 Omicron Variations in Tianjin Municipality, China 2022

Molecular epidemiological characteristics of SARS-CoV-2 in imported cases from 2021 to 2022 in Zhejiang Province, China

Genomic Surveillance for SARS-CoV-2 — China, September 26, 2022 to January 29, 2023

Genomic epidemiology of a densely sampled COVID-19 outbreak in China

Genomic epidemiology reveals the variation and transmission properties of SARS-CoV-2 in a single-source community outbreak

Genome-wide data inferring the evolution and population demography of the novel pneumonia coronavirus (SARS-CoV-2)

Epidemiological and Genomic Analysis of SARS-CoV-2 in 10 Patients From a Mid-Sized City Outside of Hubei, China in the Early Phase of the COVID-19 Outbreak

Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing

Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis

Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China

Molecular Phylogenesis and Spatiotemporal Spread of SARS-CoV-2 in Southeast Asia

Systematic Genomic Surveillance of SARS-CoV-2 at Xiamen International Airport and the Port of Xiamen Reveals the Importance of Incoming Travelers in Lineage Diversity

Genome Surveillance of SARS-CoV-2 Variants in Wuhan in June 2023

Prevalence and diversity of imported severe acute respiratory syndrome coronavirus 2 variants in China, 2021–2022

Transmission and Containment of the SARS-CoV-2 Delta Variant of Concern in Guangzhou, China: A Population-Based Study